Module 3 of 8 · Before you build

Module 3 of 8 · after Funding a Medical Device Company · next Build & Prepare to Launch

FDA & Regulatory Path

This module covers the marketing implications of the regulatory pathway. It is informational and is not regulatory, legal, or clinical advice. Your regulatory pathway, filings, and the claims you are permitted to make must be determined with your own regulatory counsel and quality team. Nothing here should be read as guidance on how to obtain clearance or approval.

For a marketer, the regulatory pathway is not a legal detail to hand off and forget. It is the single biggest constraint on what you can say, when you can say it, and how you launch. The route your device takes shapes your timeline, your permitted claims, and the entire shape of your go to market plan. The goal at this stage is to understand those implications early enough that your brand, website, sales materials, and launch calendar are built to fit them, not rebuilt after the fact.

The practical marketing questions this stage answers are these. What claims can the company make, and when? What language is safe to use in describing the device before clearance, and what has to wait? How does the expected timing of clearance drive the launch calendar, the content pipeline, and the sales enablement schedule? And how do you keep the marketing team, the sales team, and the regulatory team aligned so nothing goes public that the regulatory posture does not support?

What breaks if you skip this alignment is expensive and avoidable. Marketing that gets ahead of the regulatory position creates claims risk. A website or sales deck built on language the company cannot substantiate has to be pulled and reworked. A launch calendar that ignores the realistic clearance timeline either slips embarrassingly or pressures the team to publish before the device is cleared to be promoted that way. The device companies that launch cleanly are the ones whose marketing and regulatory functions were talking to each other from the start.

Everything downstream, your launch in Module 5 and your commercial materials in Module 6, depends on the claims discipline established here. Build it with your regulatory counsel in the room.

Core lessons

Start here

  1. Lesson 1 FDA Marketing Compliance: What Medical Device Companies Get Wrong Avoid costly FDA marketing compliance mistakes. 510(k) vs FDA approved, off-label promotion rules, clinical claims, and social media guidelines.
  2. Lesson 2 Building a Regulatory Marketing Review Process The promotional review process is the single most important compliance mechanism in medical device marketing.
  3. Lesson 3 FDA 510(k) Clearance Marketing: What You Can and Cannot Say Comprehensive guide to fda 510k clearance marketing claims for medical device companies and healthcare marketers.
  4. Lesson 4 Marketing Strategy After 510(k) Clearance The day your 510(k) clears is one of the most significant milestones in a medical device company's life.
  5. Lesson 5 FDA Cleared vs FDA Approved: What You Can Legally Say in Your Medical Device Marketing 510(k) cleared is not FDA approved. Learn the exact phrases that are safe, which ones trigger misbranding risk, and how to audit your copy before launch.
  6. Lesson 6 De Novo Classification Marketing: How to Position a New Device Category Comprehensive guide to de novo classification device marketing for medical device companies and healthcare marketers.
  7. Lesson 7 PMA Device Marketing: Navigating Claims for Premarket Approved Devices Comprehensive guide to pma device marketing claims for medical device companies and healthcare marketers.
  8. Lesson 8 ISO 13485 and Marketing: Quality System Requirements for Device Marketers Comprehensive guide to iso 13485 marketing requirements for medical device companies and healthcare marketers.
  9. Lesson 9 Medical Device Clinical Evidence Content: Using Data in Marketing Comprehensive guide to medical device clinical evidence marketing for medical device companies and healthcare marketers.
  10. Lesson 10 Marketing Clinical Claims for Medical Devices Clinical claims are the backbone of medical device marketing. When a surgeon is evaluating your device against a competitor, the claims you make about
  11. Lesson 11 Anti-Kickback Statute & Medical Device Marketing (2026) Comprehensive guide to anti kickback law medical device marketing for medical device companies and healthcare marketers.
  12. Lesson 12 Paying Physicians for Promotional Activities: What's Legal and What's Not Comprehensive guide to paying physicians promotional activities compliance for medical device companies and healthcare marketers.
  13. Lesson 13 HIPAA Marketing Compliance for Medical Device Companies Comprehensive guide to hipaa marketing compliance medical devices for medical device companies and healthcare marketers.
  14. Lesson 14 FDA Social Media Guidelines for Medical Devices Social media has transformed how medical device companies connect with healthcare professionals, patients, and the broader market.
  15. Lesson 15 Off-Label Medical Device Marketing: Legal Boundaries and Risks Comprehensive guide to off label medical device marketing for medical device companies and healthcare marketers.
Go deeper (8 more)
CE Marking Marketing Strategy (2026 EU Positioning)EU MDR Impact on Medical Device MarketingFDA Warning Letters: Marketing LessonsFDA Import Alert and Marketing Response StrategyPost-Market Surveillance Marketing: Communicating Safety DataMedical Device Product Recall Communication StrategyAdverse Event Communication for Medical Device CompaniesUDI and Marketing: Using Unique Device Identifiers in Your Digital Strategy
Free resource

The Medical Device Marketing Playbook

A single guide covering surgeon targeting, FDA-aware messaging, SEO, and launch. Useful at every stage of the Roadmap.

Take the whole Playbook with you

This stage is about learning, not buying. Start with the free guide above, and when you are ready to talk strategy, we are here.

When you are ready, talk to us →
Next: Module 4 Build & Prepare to Launch With the regulatory position understood and your claims discipline set, it is time to build the brand and commercial foundation. Continue to Module 4: Build and Prepare to Launch. Continue →
← Back to the full roadmap Previous: Module 2 · Funding a Medical Device Company
Common questions

FDA & Regulatory Path questions

How does the FDA regulatory pathway affect medical device marketing?

The regulatory pathway determines what you can claim about a device, what language is permitted before and after clearance, and how your launch is timed. A device’s cleared or approved indications define the boundaries of its marketing claims. Because of this, marketing has to be built around the regulatory position rather than ahead of it. The specifics of what your company may claim must be confirmed with your regulatory counsel; marketing’s job is to work inside those boundaries.

Can you market a medical device before it is FDA cleared?

What you can and cannot say about a device before clearance is a regulatory question that must be answered by your regulatory counsel, and it depends on your device and pathway. From a marketing planning standpoint, the practical point is that pre-clearance activity carries real constraints on promotional claims, so the marketing calendar and content pipeline should be planned around the regulatory position rather than assuming a device can be promoted freely before it is cleared. Align every pre-launch asset with your regulatory team.

What is a regulatory strategy for a medical device?

A regulatory strategy is the plan for which pathway a device will take and how it will meet the requirements of that pathway. It is owned by regulatory and quality professionals, not marketing. For the commercial team, the regulatory strategy matters because it drives timeline and permitted claims. Marketers should understand it well enough to build a launch plan that fits it, and should treat the regulatory team as the authority on what the company is allowed to say.

Why should marketing and regulatory teams work together early?

Marketing and regulatory teams should coordinate early because marketing built ahead of the regulatory position creates claims risk and rework. When the two functions align from the start, the brand, website, sales materials, and launch calendar are all built to fit what the company can actually say and when. Coordinating late means pulling and rebuilding assets after they are already public, which is slower and more expensive than getting it right the first time.

How does clearance timing affect a launch calendar?

Clearance timing sets the earliest realistic date for a full commercial launch, so it should anchor the marketing calendar. Content, sales enablement, and launch campaigns can be built during the review period, but the public launch and its associated claims have to line up with the regulatory position. Building the launch calendar around a realistic clearance timeline, confirmed with your regulatory team, avoids both premature promotion and last-minute slips.